arrow
F

Frank M. Brunkhorst

universitätsklinikum jena
H指数:70
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Macrophage Activation-Like Syndrome in critically ill patients with sepsis: high risk patients with high mortality

脓毒症危重症患者中的巨噬细胞活化样综合征:高风险患者具有高死亡率

2025-11-100
OAAI
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial

托珠单抗、萨利鲁单抗和阿那白滞素在危重症COVID-19患者中的应用:一项随机、对照、开放标签、适应性平台试验

THORAX
IF7.7
2025-05-130
PRE
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

分析脓毒症中失调的免疫反应: 克服挑战以实现精准医学的目标

2024-04-0128
OAAI
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对新型冠状病毒肺炎住院患者无器官支持天数的影响随机临床试验

2023-04-1135
OA
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2023-01-0379
OA
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
2022-04-0590
OA
Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry
2021-11-0529
OAAI
Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

恢复期血浆对重症新型冠状病毒肺炎患者无器官支持天数的影响: 一项随机临床试验

2021-11-02148
OA
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
2021-04-0116
OAAI
Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock
2021-03-0918
OAAI
A minimal common outcome measure set for COVID-19 clinical research

用于新型冠状病毒肺炎临床研究的最小通用结果测量集

2020-08-011.1K
OAAI
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study Rationale and Design
2020-07-01267
OAAI